KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Shares Issued: 2019-2021

Historic Shares Issued for AbCellera Biologics (ABCL) over the last 3 years, with Dec 2021 value amounting to $4.6 million.

  • AbCellera Biologics' Shares Issued fell 11.33% to $227,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $1.8 million, marking a year-over-year decrease of 36.99%. This contributed to the annual value of $4.6 million for FY2021, which is 99.12% down from last year.
  • Per AbCellera Biologics' latest filing, its Shares Issued stood at $4.6 million for FY2021, which was down 99.12% from $522.8 million recorded in FY2020.
  • Over the past 5 years, AbCellera Biologics' Shares Issued peaked at $522.8 million during FY2020, and registered a low of $25,000 during FY2019.
  • Its 3-year average for Shares Issued is $175.8 million, with a median of $4.6 million in 2021.
  • In the last 5 years, AbCellera Biologics' Shares Issued surged by 2,091,260.00% in 2020 and then plummeted by 99.12% in 2021.
  • AbCellera Biologics' Shares Issued (Yearly) stood at $25,000 in 2019, then skyrocketed by 2,091,260.00% to $522.8 million in 2020, then plummeted by 99.12% to $4.6 million in 2021.